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Abstract
Background: Bronchial Hyperresponsiveness (BHR) is considered a hallmark of asthma. Other methods are helpful in 
epidemiological respiratory health studies including Fractional Exhaled Nitric Oxide (FENO) and Eosinophils Percentage 
(EP) in nasal lavage fluid measuring markers for airway inflammation along with the Forced Oscillatory Technique 
measuring Airway resistance (AR). Can their outcomes discriminate profiles of respiratory health in healthy subjects 
starting apprenticeship in occupations with a risk of asthma?
Methods: Rhinoconjunctivitis, asthma-like symptoms, FEV1 and AR post-Methacholine Bronchial Challenge (MBC) test 
results, FENO measurements and EP were all investigated in apprentice bakers, pastry-makers and hairdressers not 
suffering from asthma. Multiple Correspondence Analysis (MCA) was simultaneously conducted in relation to these 
groups and this generated a synthetic partition (EI). Associations between groups of subjects based on BHR and EI 
respectively, as well as risk factors, symptoms and investigations were also assessed.
Results: Among the 441 apprentice subjects, 45 (10%) declared rhinoconjunctivitis-like symptoms, 18 (4%) declared 
asthma-like symptoms and 26 (6%) suffered from BHR. The mean increase in AR post-MBC test was 21% (sd = 20.8%). 
The median of FENO values was 12.6 ppb (2.6-132 range). Twenty-six subjects (6.7%) had EP exceeding 14%. BHR was 
associated with atopy (p < 0.01) and highest FENO values (p = 0.09). EI identified 39 subjects with eosinophilic 
inflammation (highest values of FENO and eosinophils), which was associated with BHR and atopy.
Conclusions: Are any of the identified markers predictive of increased inflammatory responsiveness or of 
development of symptoms caused by occupational exposures? Analysis of population follow-up will attempt to 
answer this question.
Background
There are many tests for investigating Occupational and
non-Occupational asthma (OA). Traditionally, attention
has been focused on airway obstruction indicators such
as Forced Expiratory Volume in 1 second (FEV1), Airway
Resistance (AR) and measurement of non-specific Bron-
chial Hyperresponsiveness (BHR). More recently, airway
inflammation indicators have gained acceptance, includ-
ing induced sputum cell counts or Fractional Exhaled
Nitric Oxide (FENO)[1].
In patients with mild to moderate asthma, FENO has
been found to correlate with BHR, reversibility of airway
obstruction, serum Eosinophil Cationic Protein (ECP),
blood eosinophilia[2] and AR parameters post methacho-
line[3]. Among adolescents in clinical remission and
without treatment for atopic asthma, FENO has been also
correlated with BHR[4]. In patients with rhinitis, a rela-
tionship has been found between sputum eosinophil
numbers[5,6] or eosinophil numbers in a nasal smear[7]
or sputum ECP level[6] and BHR.
Associations between airway responsiveness and
inflammation markers have therefore been widely studied
in the clinical field and have confirmed their clinical sig-
nificance in relation to diagnosing disease or monitoring
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drug responsiveness[1,8,9]. In a recent publication, Olin
et al. have shown that increased FENO can predict new-
onset wheeze in a general population[10]. However, little
is known concerning the helpfulness of these markers in a
healthy population exposed to airborne hazardous sub-
stances that may trigger OA.
This paper presents baseline descriptive data on respi-
ratory health and operation in non-asthmatic apprentices
recently recruited for training in occupations subject to
asthma risk. In particular, we have tried to identify cross-
sectionally fragile subgroups on inclusion in a cohort[11],
based on associations of 1) BHR (the gold standard in
terms of obstructive disorder investigation) and, 2) post-
methacholine AR, FENO, eosinophils percentages in
nasal lavage fluid and symptoms. We have considered
gender, training history, atopy and smoking habits.
Methods
The protocol has been detailed previously[11]. Briefly, all
apprentice bakers, pastry-makers and hairdressers start-
ing training programmes at six vocational schools in Lor-
raine, North-Eastern France, were invited to take part in
research. Those who accepted were included, provided
they had neither a history of previous occupational expo-
sure to substances known to induce OA nor a history of
physician-diagnosed asthma. Three visits followed the
initial inclusion visit. The study was approved by the local
ethical committee and written consent was obtained
from the apprentices or their parents, depending on the
apprentices' ages. Only data from the first visit were used
for this study.
Questionnaire
Symptoms were assessed using a standard questionnaire,
which covered personal and demographic information,
past chest diseases and symptoms, and past and present
smoking habits[12].
Hay fever was defined as sneezing, itchy, runny or
stuffy nose occurring almost every day or from time to
time in spring or summer.
Clinical atopy was defined as hay fever and/or eczema
and/or asthma in childhood and atopy in family as
asthma or allergy in siblings and/or parents.
Rhinoconjunctivitis-like symptoms were defined as
itchy, runny, stuffy nose or sneezing and/or red, burning
or weeping eyes, except during a respiratory infection
occurring irregularly almost every day or from time to
time. Asthma-like symptoms were defined as wheezing,
chest tightness, shortness of breath or coughing, except
during a respiratory infection or under exercise condi-
tions.
Fractional Exhaled Nitric Oxide (FENO)
FENO was measured according to ATS/ERS recommen-
dations[9] using a chemiluminescence analyzer (NIOX®
2.0 system; Aerocrine AB, Solna, Sweden).
FENO was expressed as observed parts per billion
(ppb) and as a percentage of predicted values based on
gender, tobacco usage status and personal atopy[13].
Pulmonary Function Tests
Pulmonary function tests were undertaken after mea-
surement of FENO (SensorMedics Corporation,
Datalink, Montpellier, France). At least three baseline
forced expiratory manoeuvres meeting recommended
criteria[14] were recorded and largest forced vital capac-
ity (FVC) and FEV1 values were recorded for analysis. A
mean oscillatory resistance of 4 to 16 Hz (Rrs4-16) was
used as outcome variable.
Non-specific airway responsiveness was assessed using
the methacholine bronchial challenge (MBC) test based
on the procedure described above[15]. Three cumulative
doses of methacholine (100, 600 and 1600 μg respec-
tively) were administered in succession[11]. The test was
finished after the last dose of methacholine or when the
FEV1 fell by 20% or more below the baseline value. In this
case, the subjects were considered as MBC+ 20%. The
difference between the maximum of Rrs4-16, after meth-
acholine inhalation increase, and baseline Rrs4-16
divided by baseline Rrs4-16 was defined as the increase in
resistance post-MBC test.
Eosinophil Count in Nasal Lavage Fluid
Nasal lavage was performed using the Hilding's
method[16]. Slides with >30% squamous cells were
rejected. Absolute cells were counted and eosinophils
percentages were calculated (EP).
Skin Prick Tests
Skin Prick Tests (SPT) were performed using dust mites,
animal danders, pollens and moulds (Stallergenes Labo-
ratories, Fresnes, France; ALK-Allerbio Laboratory,
Varennes en Argonne, France). A positive SPT was
defined as a wheal diameter 3 mm or more larger than
those obtained with the negative controls after 20 min-
utes[11]. Personal atopy was defined as the presence of a
positive response to at least one common allergen[17].
Statistical Analyses
Statistical analyses were conducted using the Stata pack-
age (Stata, College Station, TX, USA).
In order to study a priori links between inflammation
markers and hyperresponsiveness in this young healthy
population at the start of their occupational exposure,
multiple correspondence analysis (MCA) and hierarchi-
cal classifications were therefore conducted to discrimi-
nate groups of subjects. Outcome variables were those
characterising BHR; i.e. FEV1 fall and increase in Rrs4-16
post-MBC test; airway inflammation; FENO (in pre-
dicted percentages); EP; rhinoconjunctivitis- and asthma-
like symptoms. Quantitative variables were converted
into three classes of qualitative variable using the follow-Demange et al. BMC Pulmonary Medicine 2010, 10:37
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ing distribution of the post-MBC test fall of FEV1, i.e.
MBC+ 20% (26 highest values of fall and higher than
20%), MBC+ 15% (33 next highest values and higher than
15%) and no fall (371 last values). For EP, the three classes
were divided into the 26 highest values and the next 25
values because only 51 values involved a detectable num-
ber of eosinophils.
We then studied the differences between subjects with
and without BHR (defined as MBC+ 20%) based on gen-
der, training history, tobacco usage status and atopy (in
family, clinical and personal) and on post-MBC test Rrs4-
16 increase, FENO and EP. We conducted the same analy-
sis with the subject groups.
Results
Four hundred and forty one apprentices were included,
representing 24% of the 1839 apprentices invited to par-
ticipate[11] (Table 1). Bakers and pastry-makers repre-
sented more than 60% of the group. Roughly half of these
subjects were non smokers with fewer female than male
smokers.
Atopy in family was more often declared by females
than by males (40% versus 33%), whereas the reverse was
found for personal atopy (36% versus 26%). SPT could not
be applied to the first 74 subjects for technical reasons.
BHR prevalence was identical in both genders, as was
symptom prevalence (approximately 10% for rhinocon-
junctivitis-like symptoms and 6% for asthma-like symp-
toms). Only one subject declared asthma-like symptoms
and was MBC+ 20% without positive SPT. The mean
increase in the AR post-MBC test was 21% (sd = 20.8%)
(data not shown).
The median of FENO values was 12.6 ppb [2.6-132
range] (data not shown). Predicted mean FENO values
were approximately 30% lower than expected[13]. How-
ever, the relationship between predicted FENO with per-
sonal atopy persisted, showing that the FENO on atopy
adjustment did not fully correct its effect [Additional file
1]. Distribution of absolute FENO values and FENO in
percent predicted according to sex, tobacco usage status
and personal atopy is shown [Additional file 2].
The prevalence of high EP was almost twice as great in
males as in females (Table 1). The EP of 26 subjects (6.7%)
exceeded 14%.
The two axes produced by MCA and hierarchical clas-
sification explain 70% of the variance and allow us to dis-
tinguish four groups of items [Additional file 3]. The
highest FENO and EP values lie to the left of the horizon-
tal axis (group 1), whilst highest BHR level and EP mid-
value lie on the right of this axis (group 2). In relation to
the vertical axis, presence of symptoms and highest resis-
tances lie above the axis (group 3), whilst FENO, EP and
highest BHR level lie below the axis. Absence of symp-
toms or lowest test values lie at the origin of both axes
and have no discriminating effect (group 4). The BHR
mid-level has no discriminating effect on the vertical axis.
The horizontal axis appears to agree closely with inflam-
mation markers, whilst the vertical axis agrees closely
with presence of symptoms and AR.
A second hierarchical subject classification based on
proximity to the four item groups only identified two sub-
ject groups because of the small numbers of subjects
defined by the group 2 and 3 items. These were therefore
regrouped with the group 1 items. The widest group
comprised 302 subjects without symptoms and/or the
lowest outcome values. The second group comprised 39
subjects mostly defined by highest FENO or EP values.
These two markers were strongly and positively associ-
ated (p < 0.001) (Table 2). We therefore called this group
"positive eosinophilic inflammation" (EI+) and the widest
group "negative eosinophilic inflammation" (EI-).
Personal atopy only reached statistical significance,
when considering apprentices with respect to BHR (Table
3). BHR at inclusion was unrelated to gender, training his-
tory, tobacco usage status and predicted FEV1 percent-
age. Atopy in family was more frequent in subjects with,
rather than without, BHR (p = 0.19). More than 60% of
subjects with BHR were atopic compared to 28% without
B H R .  H i g h  v a l u e s  o f  F E N O  a n d  E P  w e r e  m o r e  o f t e n
observed in the BHR group, but this relationship did not
reach statistical significance.
There was no difference between groups EI+ and EI-
regarding gender, training history, tobacco usage status
and predicted FEV1 percentage (Table 4). There were
more than twice cases with personal atopy in the EI+
group than in EI- group. More specifically, personal atopy
was strongly associated with predicted FENO percentage
(p < 0.001), but not with EP (p = 0.15) [Additional file 1].
Similarly, BHR prevalence was twice as great in the EI+
group than in the EI- group. The highest increases in
Rrs4-16 were more often observed in the EI+ group, but
the difference was not statistically significant. This was
the same for symptoms. The EI+ group had higher values
of FENO and this was statistically significant. Similar
associations were found for the highest EP values.
Discussion
I n  t h i s  s t u d y ,  w e  h a v e  d e s c r i b e d  a s s o c i a t i o n s  o f  f o u r
markers of airway responsiveness or inflammation and
clinical symptoms in a young non-asthmatic population
at the start of occupational exposure. We have identified
different fragile groups, especially a group with airway
eosinophilic inflammation, more frequent BHR and
atopy.
As expected, our apprentice population exhibits the
characteristics of a healthy population. Mean observed
baseline FVC and FEV1 were higher than 90% of pre-
dicted values. Prevalence of symptom[18,19] andDemange et al. BMC Pulmonary Medicine 2010, 10:37
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Table 1: Characteristics of the apprentice cohort at baseline (% (n), mean [sd]).
Males Females Total
n 56.9% (251) 43.1% (190) 441
Training track
Bakery 60.6% (152) 4.7% (9) 36.5% (161)
Pastry 34.7% (87) 12.6% (24) 25.2% (111)
Hairdressing 4.8% (12) 82.6% (157) 38.3% (169)
Age (years) 16.8 [1.1] 17.1 [1.7] 16.9 [1.4]
Body Mass Index 22.1 [4.1] 21.9 [3.7] 22.0 [3.9]
Tobacco consumption
Current smokers 51.4% (129) 41.1% (78) 46.9% (207)
Age at starting smoking 14.0 [1.6] 13.7 [1.8] 13.9 [1.7]
Pack years 1.7 [1.6] 1.7 [1.6] 1.7 [1.6]
Past smokers 2.0% (5) 4.2% (8) 3.0% (13)
Non-smokers 46.6% (117) 54.7% (104) 50.1% (221)
Atopy in family* 32.7% (82) 40.0% (76) 35.8% (158)
Clinical atopy† 20.7% (52) 20.5% (39) 20.6% (91)
Personal atopy‡ (97 missing data) 35.7% (70) 25.7% (38) 31.4% (108)
Baseline spirometry§
Missing data (% (n)) 1.6% (4) 1.1% (2) 1.4% (6)
FEV1 91.4 [11.0] 93.6 [9.5] 92.3 [10.4]
FVC 90.7 [12.0] 92.0 [10.6] 91.3 [11.4]
FEV1/FVC (%) 101.3 [8.4] 102.0 [7.0] 101.6 [7.9]
Baseline airway resistance (kPa.L.s-1) 0.25 [0.07] 0.29 [0.06] 0.27 [0.07]
MBC test
Airways responsiveness
Missing data (% (n)) 3.2% (8) 1.6% (3) 2.5% (11)
MBC+ >20% 6.6% (16) 5.3% (10) 6.0% (26)
MBC+ 15 to 20% 8.2% (20) 7.0% (13) 7.7% (33)
Airway resistance
Rrs4-16 increase (%)||
>54.6% 7.4% (18) 4.5% (8) 6.2% (26)
>42.3% and <54.6% 9.1% (22) 6.2% (11) 7.8% (33)
<42.3% 83.5% (202) 89.4% (160) 86.0% (362)
Clinical indicators of airway inflammation
Rhinoconjunctivitis-like symptoms¶ 8.8% (22) 12.1% (23) 10.2% (45)
Asthma-like symptoms# 3.2% (8) 5.3% (10) 4.1% (18)
Quantitative indicators of airway inflammation
FENO in percent predicted**
>225% 6.6% (15) 6.8% (11) 6.7% (26)
>140% and <225% 8.7% (20) 8.0% (13) 8.4% (33)
<140% 84.7% (194) 85.2% (138) 84.9% (332)
Eosinophil count in nasal fluid lavage
Missing data (% (n)) 13.5% (34) 8.9% (17) 11.6% (51)Demange et al. BMC Pulmonary Medicine 2010, 10:37
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BHR[19,20] were similar to or lower than those found in
other studies of trainees starting apprenticeship and
exposed to high weight molecular agents. One study of
apprentice bakers revealed a higher prevalence of symp-
toms[20], but this might be due to the 25% of apprentices
who worked in baker shops before starting their training.
Prevalence of atopy (32%) was within the range of, or
lower than, in other European published stud-
ies[18,20,21], whilst higher prevalences (over 40%) were
found by Gautrin[19,22], but there is no straightforward
explanation for the difference between our study and
those of Canadian investigators.
Rhinoconjunctivitis- and asthma-like symptoms were
not associated with other markers in our study. Baseline
cross-sectional association between symptoms and BHR
was not examined in any apprentice study. Two cohort
studies failed to find a statistically significant relationship
between baseline BHR and incidence of work-related
symptoms[23,24]. However, Gautrin found that baseline
BHR was significantly associated with development of
non-work-related asthma symptoms[19]. Our definition
of symptoms was not restricted to work-related symp-
toms because occupational exposure had just started and
it is therefore not surprising that the baseline declared
symptoms are not associated with airway inflammation
or responsiveness markers.
The fact that the BHR post-MBC test was unrelated to
increased AR post methacholine inhalation was unex-
pected, while it being well known that there is significant
correlation between changes in resistance and FEV1 fol-
lowing bronchoconstriction[25]. However, this correla-
tion has been found in workers or in patients, very
different from our population of apprentices about length
of exposure and health status.
Neither did we discover a relationship between BHR
and FENO. Two studies based on community population
enrolment have shown that BHR is associated with FENO
in atopics only[26,27]. The same atopic-based relation-
ship was found in a population of male conscripts similar
to the population used in our study[28].
In our study, BHR proved unrelated to FENO whatever
the atopic status (data not shown). However, the study
population was effectively different from ours. That is, it
featured higher prevalence of atopy (over 50%) and BHR
(over 16%) and included asthmatics.
We found that BHR was independent of EP. According
to literature, eosinophil numbers in induced sputum is
more often used than the same count in nasal lavage fluid
and was not significantly associated with BHR in 32
healthy controls used in a comparative study of airway
inflammation and epithelial damage in swimmers and
cold-air athletes[29].
Based on the combined markers of airway inflamma-
tion and hyperresponsiveness, we found that two axes
effectively structure the data: one involving airway
inflammation and one involving symptoms and AR. We
performed a further analysis based on predicted FEV1
percentage and these axes and the item groups remained
the same in this analysis [Additional file 4]. This strength-
>1% 6.5% (14) 6.4% (11) 6.4% (25)
>14% 8.3% (18) 4.6% (8) 6.7% (26)
Rrs4-16: mean oscillatory resistance from 4 to 16 Hz; MBC Methacholine Bronchial Challenge test.
* asthma or allergy in siblings and/or parents; † hay fever and/or eczema in childhood and/or asthma in childhood; ‡ defined as a positive 
response to at least one common allergen at the Skin Prick Tests
§ in percent predicted according to the European Respiratory Society
|| increase = 100.(maximum of Rrs after methacholine inhalation - baseline Rrs)/baseline Rrs
¶ in case of itchy, runny, stuffy nose, or sneezes and/or about red, burning or weeping eyes, excepted during a respiratory infection
# in case of wheezing, chest tightness, shortness of breath, or cough, excepted during a respiratory infection or under exercise condition;** 
according to gender, tobacco usage status and personal atopy ([13])
Table 1: Characteristics of the apprentice cohort at baseline (% (n), mean [sd]). (Continued)
Table 2: Association between FENO and eosinophils percentages in nasal lavage fluid as qualitative variables 
(percentages in column) (N = 341).
FENO in percent predicted according to Travers*
Percentages of eosinophils <140% >140% and <225% >225%
<1% 88.5% (261) 84.0% (21) 57.1% (12)
>1% and <14% 7.5% (22) 0% (0) 4.8% (1)
>14% 4.1% (12) 16.0% (4) 38.1% (8)
*according to gender, tobacco usage status and personal atopy ([13])Demange et al. BMC Pulmonary Medicine 2010, 10:37
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Table 3: Associations between MBC test outcome and constitutional, behavioural characteristics and markers of airway 
responsiveness and inflammation (percentage in column (n)) (N = 341).
MBC- FEV1's fall <20% (N = 322) MBC FEV1's fall ≥20% (N = 19) p
Constitutional characteristics
Gender: Male 56.2% (181) 52.6% (10) 0.76
Atopy in family* 37.6% (121) 52.6% (10) 0.19
Clinical atopy† 19.9% (64) 10.5% (2) 0.55**
Personal atopy‡ (61 missing data) 27.4% (72) 64.7% (11) <0.01**
Behavioural characteristics
Training track
Bakery 36.3% (117) 26.3% (5)
Pastry making 25.5% (82) 26.3% (5) 0.69**
Hairdressing 38.2% (123) 47.4% (9)
Tobacco usage status
Non smoker 49.4% (159) 42.1% (8)
Current smoker 47.2% (152) 52.6% (10) 0.54**
Past smoker 3.4% (11) 5.3% (1)
Baseline FEV1§
>80.8% 86.3% (278) 79.0% (15)
>76.0% and <80.7% 8.7% (28) 10.5% (2) 0.31**
<76.0% 5.0% (16) 10.5% (2)
Rrs4-16 increase post MBC test (%)
(mean (sd))
<42.4% 87.3% (281) 84.2% (16)
>42.4% and <54.6% 6.8% (22) 10.5% (2) 0.75**
>54.6% 5.9% (19) 5.3% (1)
Clinical indicators of airway inflammation
Rhinoconjunctivitis-like symptoms|| 9.6% (31) 5.3% (1) 1.0**
Asthma-like symptoms¶ 4.0% (13) 5.3% (1) 0.56**
Quantitative indicators of airway inflammation
FENO in ppb (median (first-third quartiles) 12.4 (8.9-17.6) 16.4 (10.3-35.0) 0.19††
FENO in percent predicted according to Travers#
<140% 87.3% (281) 73.7% (14)
>140% and <225% 7.1% (23) 10.5% (2) 0.09**
>225% 5.6% (18) 15.8% (3)
Eosinophil count in nasal fluid lavage
<1% 86.7% (279) 79.0% (15)
>1% and <14% 6.5% (21) 10.5% (2) 0.37**
>14% 6.8% (22) 10.5% (2)
Rrs4-16: mean oscillatory resistance from 4 to 16 Hz; MBC: Methacholine Bronchial Challenge test.
* asthma or allergy in siblings and/or parents; † hay fever and/or eczema in childhood and/or asthma in childhood; ‡ defined as a positive 
response to at least one common allergen at the Skin Prick Tests
§ in percent predicted according to the European Respiratory Society
|| in case of itchy, runny, stuffy nose, or sneezes and/or about red, burning or weeping eyes, excepted during a respiratory infection; ¶ in case of 
wheezing, chest tightness, shortness of breath, or cough, excepted during a respiratory infection or under exercise condition.
# according to gender, tobacco usage status and personal atopy ([13])
** Fisher's exact test; †† Mann-Whitney testDemange et al. BMC Pulmonary Medicine 2010, 10:37
http://www.biomedcentral.com/1471-2466/10/37
Page 7 of 10
Table 4: Associations between groups without (EI-) and with eosinophilic inflammation (EI+) and constitutional, behavioural 
characteristics and markers of airway responsiveness and inflammation (percentage in column (n)) (N = 341).
Group EI-
(N = 302)
Group EI+
(N = 39)
p
Constitutional characteristics
Gender: Male 56.3% (170) 53.9% (21) 0.77
Atopy in family* 37.1% (112) 48.7% (19) 0.16
Clinical atopy† 19.9% (60) 15.4% (6) 0.67**
Personal atopy‡ (61 missing data) 25.7% (64) 61.3% (19) <0.001
Behavioural characteristics
Training track
Bakery 36.8% (111) 28.2% (11)
Pastry making 23.8% (72) 38.5% (15) 0.14
Hairdressing 39.4% (119) 33.3% (13)
Tobacco usage status
Non smoker 48.0% (145) 56.4% (22)
Current smoker 48.7% (147) 38.5% (15) 0.36**
Past smoker 3.3% (10) 5.1% (2)
Baseline FEV1§
>80.8% 86.1% (260) 84.6% (33)
>76.0% and <80.7% 8.9% (27) 7.7% (3) 0.70**
<76.0% 5.0% (15) 7.7% (3)
MBC test
Airways responsiveness
MBC- 88.1% (266) 69.2% (27)
MBC+ ≥15 and <20% (% (n)) 7.3% (22) 18.0% (7) <0.01**
MBC+ ≥20% (% (n)) 4.6% (14) 12.8% (5)
Rrs4-16 increase (%)
(mean (sd))
<42.4% 88.1% (266) 79.5% (31)
>42.4% and <54.6% 7.0% (21) 7.7% (3) 0.13**
>54.6% 5.0% (15) 12.8% (5)
Clinical indicators of airway inflammation
Rhinoconjunctivitis-like symptoms|| 8.6% (26) 15.4% (6) 0.24**
Asthma-like symptoms¶ 3.6% (11) 7.7% (3) 0.21**
Quantitative indicators of airway inflammation
FENO in ppb (median (first-third quartiles)) 12.0 (8.7-16.6) 50.8 (20.4-69.5) <0.0001††
FENO in percent predicted#
<140% 93.4% (282) 33.3% (13)
>140% and <225% 6.6% (20) 12.8% (5) <0.001**
>225% 0 53.9% (21)
Eosinophil count in nasal fluid lavage
<1% 93.1% (281) 33.3% (13)Demange et al. BMC Pulmonary Medicine 2010, 10:37
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ens our conclusion that both FENO and EP are compo-
nents of our data structure.
Eosinophilic inflammation revealed a statistically sig-
nificant association with BHR, whilst BHR-FENO and
BHR-EP associations were statistically insignificant. This
might be due to greater power through an increase in the
number of subjects with eosinophilic inflammation either
based on FENO or EP.
The relationship between eosinophilic inflammation
and increased AR post-MBC test is stronger than
between BHR and AR (p = 0.13, p = 0.75 respectively).
This was unexpected and, as far as we know, the first time
AR and FENO or EP have been analysed together.
We found eosinophilic inflammation to be strongly
associated with personal atopy. This is meaningful
because atopy is not used to build groups with MCA and
hierarchical classifications, whereas FENO, eosinophils
and BHR are. The relationship between increased FENO
and atopy is well known[9] and an understanding of
FENO values requires atopy assessment[13]. Atopy was
associated with increased eosinophil counts in induced
sputum in 50 healthy subjects[30]. Amongst healthy
adults, personal atopy is significantly associated with
higher eosinophil counts[31]. In our study, atopy is signif-
icantly associated with BHR, post-MBC test AR, FENO,
e x c e p t  w i t h  E P  [ A d d i t i o n a l  f i l e  1 ] .  C o m b i n e d  u s e  o f
FENO and EP may have proved a more powerful method
of revealing an association.
One strength of this study is that it is based on one of
the widest European apprentice cohorts. The drop-out is
low (20%)[11] and it represents a healthy population at
the start of occupational exposure, thereby allowing us to
consider early disorders. Another strength is that several
markers were collected and analysed together, especially
FENO, which studied for the first time among appren-
tices. On the other hand, a weakness of this study is that it
is based on cross-sectional analysis and the clinical signif-
icance of the different identified groups is still unknown.
Olin et al. have shown that increased FENO is predictive
of wheeze 4 years later in a baseline non asthmatic non
wheezing general population[10]. Our cohort follow-up
has now been completed and we'll seek if our results sup-
port her hypothesis that increased FENO is a sign of sub-
clinical inflammation in the near future.
Conclusions
In a young non-asthmatic population at the beginning of
occupational exposure, we have identified cross-section-
ally different groups defined by their airway inflamma-
tion markers. The longitudinal follow up of this
population will allow to check whether these groups are
predictive of an aggravation.
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Additional file 1 Table One. Description of associations between atopy 
and gender, behavioural characteristics and markers of airway responsive-
ness and inflammation.
>1% and <14% 7.0% (21) 5.1% (2) <0.001**
>14% 0 61.5% (24)
Rrs4-16: mean oscillatory resistance from 4 to 16 Hz; MBC Methacholine Bronchial Challenge test.
* asthma or allergy in siblings and/or parents; † hay fever and/or eczema in childhood and/or asthma in childhood; ‡ defined as a positive 
response to at least one common allergen at the Skin Prick Tests
§ in percent predicted according to the European Respiratory Society
|| in case of itchy, runny, stuffy nose, or sneezes and/or about red, burning or weeping eyes, excepted during a respiratory infection; ¶ in case 
of wheezing, chest tightness, shortness of breath, or cough, excepted during a respiratory infection or under exercise condition.
# according to gender, tobacco usage status and personal atopy ([13])
** Fisher's exact test; †† Mann-Whitney test
Table 4: Associations between groups without (EI-) and with eosinophilic inflammation (EI+) and constitutional, behavioural 
characteristics and markers of airway responsiveness and inflammation (percentage in column (n)) (N = 341). (Continued)Demange et al. BMC Pulmonary Medicine 2010, 10:37
http://www.biomedcentral.com/1471-2466/10/37
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Abbreviations
AR: Airway Resistance; BHR: Bronchial Hyperresponsiveness; ECP: Eosinophil
Cationic Protein; EI: Eosinophilic Inflammation; EP: Eosinophils Percentages in
nasal lavage fluid; FENO: Fractional Exhaled Nitric Oxide; FEV1: Forced Expira-
tory Volume in 1 second; FVC: Forced Vital Capacity; MBC: Methacholine Bron-
chial Challenge; MCA: Multiple Correspondence Analysis; OA: Occupational
Asthma; Rrs4-16: Resistance from 4 to 16 Hz; Sd: Standard deviation; SPT: Skin
Prick Test.
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